Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjögren's syndrome

Malladi, 2012, Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry, Arthritis Care Res., 64, 911, 10.1002/acr.21610 Kiripolsky, 2017, Innate immunity in Sjogren's syndrome, Clin. Immunol., 182, 4, 10.1016/j.clim.2017.04.003 Lessard, 2013, Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome, Nat. Genet., 45, 1284, 10.1038/ng.2792 Mavragani, 2014, Sjogren's syndrome, Annu. Rev. Pathol., 9, 273, 10.1146/annurev-pathol-012513-104728 Medzhitov, 1998, MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways, Mol Cell, 2, 253, 10.1016/S1097-2765(00)80136-7 Pasare, 2005, Control of B-cell responses by Toll-like receptors, Nature, 438, 364, 10.1038/nature04267 Schenten, 2014, Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells, Immunity, 40, 78, 10.1016/j.immuni.2013.10.023 Schnare, 2001, Toll-like receptors control activation of adaptive immune responses, Nat. Immunol., 2, 947, 10.1038/ni712 Kiripolsky, 2017, Myd88 is required for disease development in a primary Sjogren's syndrome mouse model, J. Leukoc. Biol., 102, 1411, 10.1189/jlb.3A0717-311R Kiripolsky, 2019, Activation of myd88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary sjogren's syndrome, Front. Immunol., 10, 2963, 10.3389/fimmu.2019.02963 Kiripolsky, 2018, Current and emerging evidence for toll-like receptor activation in sjogren's syndrome, J Immunol Res, 2018, 1246818, 10.1155/2018/1246818 Spachidou, 2007, Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome, Clin. Exp. Immunol., 147, 497, 10.1111/j.1365-2249.2006.03311.x Kwok, 2012, TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome, Arthritis Res. Ther., 14, R64, 10.1186/ar3780 Karlsen, 2015, Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjogren's syndrome, PloS One, 10, 10.1371/journal.pone.0120383 Woods, 2012, P2X7 receptor activation induces inflammatory responses in salivary gland epithelium, Am. J. Physiol. Cell Physiol., 303, C790, 10.1152/ajpcell.00072.2012 Khalafalla, 2017, P2X7 receptor antagonism prevents IL-1 beta release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy, J. Biol. Chem., 292, 16626, 10.1074/jbc.M117.790741 Bulosan, 2009, Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren's syndrome before disease onset, Immunol. Cell Biol., 87, 81, 10.1038/icb.2008.70 Baldini, 2013, The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome, J. Intern. Med., 274, 480, 10.1111/joim.12115 Ciccia, 2015, Interleukin-36 alpha axis is modulated in patients with primary Sjogren's syndrome, Clin. Exp. Immunol., 181, 230, 10.1111/cei.12644 Vakrakou, 2018, Systemic activation of NLRP3 inflammasome in patients with severe primary Sjogren's syndrome fueled by inflammagenic DNA accumulations, J. Autoimmun., 91, 23, 10.1016/j.jaut.2018.02.010 Blokland, 2019, Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjogren’s syndrome, Rheumatology Manoussakis, 2007, Arthritis Rheum., 56, 3977, 10.1002/art.23073 Imgenberg-Kreuz, 2019, Shared and unique patterns of DNA methylation in systemic lupus erythematosus and primary sjogren's syndrome, Front. Immunol., 10, 1686, 10.3389/fimmu.2019.01686 Shah, 2017, Biosemantics guided gene expression profiling of Sjogren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis, Arthritis Res. Ther., 19, 192, 10.1186/s13075-017-1400-3 Teruel, 2016, Genetics of systemic lupus erythematosus and Sjogren’s syndrome: an update, Curr. Opin. Rheumatol., 28, 506, 10.1097/BOR.0000000000000310 Sadanaga, 2007, Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice, Arthritis Rheum., 56, 1618, 10.1002/art.22571 Lau, 2005, RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement, J. Exp. Med., 202, 1171, 10.1084/jem.20050630 Nickerson, 2010, TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus, J. Immunol., 184, 1840, 10.4049/jimmunol.0902592 Teichmann, 2013, Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus, Immunity, 38, 528, 10.1016/j.immuni.2012.11.017 Hua, 2014, Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice, J. Immunol., 192, 875, 10.4049/jimmunol.1300683 Kiripolsky, 2017, Systemic manifestations of primary Sjogren's syndrome in the NOD.B10Sn-H2b/J mouse model, Clin. Immunol., 183, 225, 10.1016/j.clim.2017.04.009 Ogilvy, 1999, Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment, Blood, 94, 1855, 10.1182/blood.V94.6.1855 Joseph, 2013, Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies, Cell Stem Cell, 13, 520, 10.1016/j.stem.2013.10.010 Wicker, 1992, Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes, J. Exp. Med., 176, 67, 10.1084/jem.176.1.67 Hou, 2008, Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms, Immunity, 29, 272, 10.1016/j.immuni.2008.05.016 Gais, 2012, Cutting edge: divergent cell-specific functions of MyD88 for inflammatory responses and organ injury in septic peritonitis, J. Immunol., 188, 5833, 10.4049/jimmunol.1200038 Robinson, 1998, A novel NOD-derived murine model of primary Sjogren's syndrome, Arthritis Rheum., 41, 150, 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T Rasband, 1997 Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 Schindelin, 2015, The ImageJ ecosystem: an open platform for biomedical image analysis, Mol. Reprod. Dev., 82, 518, 10.1002/mrd.22489 Sboner, 2009, Robust-linear-model normalization to reduce technical variability in functional protein microarrays, J. Proteome Res., 8, 5451, 10.1021/pr900412k Chan, 2015, Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015, Front. Immunol., 6, 412, 10.3389/fimmu.2015.00412 Nguyen, 2020, Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate, Microbiome, 8, 118, 10.1186/s40168-020-00887-w Benjamini, 2001, The control of the false discovery rate in multiple testing under dependency, Ann. Stat., 29, 1165, 10.1214/aos/1013699998 Shiboski, 2012, American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort, Arthritis Care Res., 64, 475, 10.1002/acr.21591 Shiboski, 2018, Natural history and predictors of progression to sjogren's syndrome among participants of the sjogren's international collaborative clinical alliance registry, Arthritis Care Res., 70, 284, 10.1002/acr.23264 Lamagna, 2014, B cell-specific loss of Lyn kinase leads to autoimmunity, J. Immunol., 192, 919, 10.4049/jimmunol.1301979 Mahmoud, 2016, Autoimmune manifestations in aged mice arise from early-life immune dysregulation, Sci. Transl. Med., 8, 361ra137, 10.1126/scitranslmed.aag0367 Roescher, 2009, Cytokines in Sjogren's syndrome, Oral Dis., 15, 519, 10.1111/j.1601-0825.2009.01582.x Sisto, 2017, TLR2 signals via NF-kappaB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjogren's syndrome, Clin. Exp. Med., 17, 341, 10.1007/s10238-016-0429-y Bouma, 2015, Aging and immunopathology in primary sjogren's syndrome, Curr. Aging Sci., 8, 202, 10.2174/1874609808666150727112826 Papinska, 2018, Activation of stimulator of interferon genes (STING) and sjogren syndrome, J. Dent. Res., 97, 893, 10.1177/0022034518760855 Papinska, 2020, Pulmonary involvement in a mouse model of sjogren's syndrome induced by STING activation, Int. J. Mol. Sci., 21, 10.3390/ijms21124512 Moreth, 2010, The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis, J. Clin. Invest., 120, 4251, 10.1172/JCI42213 Schaefer, 2005, The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages, J. Clin. Invest., 115, 2223, 10.1172/JCI23755 Piccinini, 2010, DAMPening inflammation by modulating TLR signalling, Mediat. Inflamm., 2010, 10.1155/2010/672395 Nastase, 2014, Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology, Biochim. Biophys. Acta, 1840, 2460, 10.1016/j.bbagen.2014.01.035 Zeng-Brouwers, 2020, Communications via the small leucine-rich proteoglycans: molecular specificity in inflammation and autoimmune diseases, J. Histochem. Cytochem., 68, 887, 10.1369/0022155420930303 Anders, 2014, Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis, J. Am. Soc. Nephrol., 25, 1387, 10.1681/ASN.2014010117 Merline, 2011, Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21, Sci. Signal., 4, ra75, 10.1126/scisignal.2001868 Babelova, 2009, Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors, J. Biol. Chem., 284, 24035, 10.1074/jbc.M109.014266 Kumar, 2019, A STING to inflammation and autoimmunity, J. Leukoc. Biol., 106, 171, 10.1002/JLB.4MIR1018-397RR Allushi, 2019, Hyperglycemia and salivary gland dysfunction in the non-obese diabetic mouse: caveats for preclinical studies in sjogren's syndrome, Sci. Rep., 9, 17969, 10.1038/s41598-019-54410-9 Leiter, 1989, The genetics of diabetes susceptibility in mice, Faseb. J., 3, 2231, 10.1096/fasebj.3.11.2673897 De Luca, 2019, The microbiome in autoimmune diseases, Clin. Exp. Immunol., 195, 74, 10.1111/cei.13158 Zegarra-Ruiz, 2019, A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity, Cell Host Microbe, 25, 113, 10.1016/j.chom.2018.11.009